
Affymax, Inc. Share · US00826A1097 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Affymax, Inc.
No Price
Closing Price OTC 01.05.2026:
0,001 USD
01.05.2026 14:42
Current Prices from Affymax, Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
AFFY
|
USD
|
01.05.2026 14:42
|
0,001 USD
| 0,0001 USD
+10,00 %
|
Company Profile for Affymax, Inc. Share
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Company Data
Name Affymax, Inc.
Company Affymax, Inc.
Website
https://www.affymax.com
Primary Exchange
UTC
ISIN US00826A1097
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Jonathan M. Couchman CFA
Country United States of America
Currency USD
Employees 0,0 T
Address 630 Fifth Avenue, 10020 New York City
IPO Date 2006-12-15
Dividends from 'Affymax, Inc.'
| Ex-Date | Dividend per Share |
|---|---|
| 24.12.2014 | 0,05 USD |
| 28.11.2014 | 0,05 USD |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | AFFY |
More Shares
Investors who hold Affymax, Inc. also have the following shares in their portfolio:

